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Abstract 
 
Blood oxygenation level dependent (BOLD) contrast fMRI is a widely used technique to map 
brain function, and to monitor its recovery after stroke. Since stroke has a vascular etiology, 
the neurovascular coupling between cerebral blood flow and neural activity may be altered, 
resulting in uncertainties when interpreting longitudinal BOLD signal changes. The purpose 
of this study was to demonstrate the feasibility of using a recently validated breath-hold task 
in patients with stroke, both to assess group level changes in cerebrovascular reactivity 
(CVR) and to determine if alterations in regional CVR over time will adversely affect 
interpretation of task-related BOLD signal changes. Three methods of analyzing the breath-
hold data were evaluated. The CVR measures were compared over healthy tissue, infarcted 
tissue, and the peri-infarct tissue, both sub-acutely (~two weeks) and chronically (~four 
months). In this cohort, a lack of CVR differences in healthy tissue between the patients and 
controls indicates that any group level BOLD signal change observed in these regions over 
time is unlikely to be related to vascular alterations. CVR was reduced in the peri-infarct 
tissue but remained unchanged over time. Therefore, although a lack of activation in this 
region compared to the controls may be confounded by a reduced CVR, longitudinal group-
level BOLD changes may be more confidently attributed to neural activity changes in this 
cohort. By including this breath-hold based CVR assessment protocol in future studies of 
stroke recovery, researchers can be more assured that longitudinal changes in BOLD signal 
reflect true alterations in neural activity.  
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Introduction 
 
Over recent decades, functional magnetic resonance imaging (fMRI) has become a useful 
tool when studying the recovery of brain function following a stroke or other focal brain injury. 
Interpretations of fMRI findings should take into account the limitations of this technique, and 
factors that influence the fMRI derived Blood Oxygen Level Dependent (BOLD) signal 
(Logothetis, 2008). BOLD contrast fMRI is not only dependent on increased oxygen 
metabolism due to increased neural activity since activation-related differences also depend 
on changes in cerebral blood flow (CBF) and cerebral blood volume (Buxton, 2012; Davis et 
al., 1998; Hoge et al., 1999). Since stroke has a vascular etiology, this may alter the normal 
neurovascular coupling between CBF and oxygen consumption (taken as representative of 
neural activity), with resulting uncertainty when interpreting BOLD signal changes. 
 
Reductions in cerebrovascular reactivity (CVR), the response of cerebral blood vessels to a 
vasodilatory stimulus, are associated with factors that predispose to stroke (Gupta et al., 
2012; Markus, 2001). Acute vascular changes as a result of stroke may further reduce CVR. 
Reductions in CVR will lead to alterations in neurovascular coupling; that is, a given change 
in neural activity will no longer be represented by the same BOLD signal change. Regional 
changes in CVR and BOLD signal have been observed in adults after stroke (Krainik et al., 
2005). Combining BOLD fMRI with a vasoactive stimulus such as CO2 provides a robust 
means of characterizing CVR (Shiino et al., 2003). In many studies of clinical populations, an 
increase in arterial CO2 levels is achieved using administration of a vasodilatory gas through 
a face mask during scanning (Heyn et al., 2010). In patients with stroke, this may not always 
be desirable or feasible due to the discomfort of the experimental setup. 
 
A simple method to measure BOLD CVR in patient groups using a breath-hold task has 
been developed (Bright and Murphy, 2013; Murphy et al., 2011). Breath-holding offers an 
alternative to gas administration, and provides a similar BOLD CVR measure (Kastrup et al., 
2001). Until recently it had been assumed that the degree of cooperation to perform a 
breath-holding task would vary too greatly across a patient population to provide a reliable 
measure of CVR (Spano et al., 2013). However, Bright and Murphy (2013) have shown that 
by monitoring end-tidal CO2 levels during a breath-hold task, robust and repeatable 
measures of CVR can be obtained, even if the breath-hold task is poorly performed. This 
opens the way to using such a task in a stroke population to account for CVR differences. 
These measures can, in turn, be used to adjust the BOLD signal to more accurately reflect 
the neural responses to stimuli in a task-related fMRI study (Murphy et al., 2011).   
 
Changes in CVR over time may potentially be problematic, particularly in longitudinal fMRI 
studies investigating recovery after the onset of stroke (Saur, 2006; Ward et al., 2003). In the 
longitudinal study by Saur and colleagues (2006), investigating language recovery following 
a left hemisphere stroke, there was no activity in the left hemisphere language areas, within 
the same vascular territory as the infarct, during the first few days after the stroke. Although 
this was interpreted as a lack of language-related neural activity caused by the stroke, an 
alternative explanation is that the absence of BOLD signal was the result of altered cerebral 
haemodynamics rather than a decline in neural activity per se. For example, it has been 
shown that the morphology of the haemodynamic response function (HRF) in the left 
perisylvian area is altered in some aphasic patients following a stroke (Bonakdarpour et al., 
2007). In another study, the characteristics of the HRF response to an auditory 
comprehension task changed as patients progressed from the acute to the sub-acute phase 
of stroke (Altamura et al., 2009). In addition, major arterial stenoses result in a compensatory 
reduction in distal cerebrovascular resistance, which in turn will alter CVR. Thus, it has been 
demonstrated that the HRF ipsilateral to an internal carotid artery stenosis has different 
temporal characteristics to that in the contralateral hemisphere (Carusone and Srinivasan, 
2002). Furthermore, large vessel cervical or cerebral artery steno-occlusive disease can 
induce competitive intra-cerebral redistribution of flow from territories with low vasodilatory 
reserve to those with high reserve (Sobczyk et al., 2014). Thus without taking into account 
acute and chronic changes in normal CVR, task-related BOLD signal changes over time, 
particularly in longitudinal studies of stroke, are prone to misinterpretation. 
 
One fMRI study investigating aphasic stroke recovery has used a simple breath-hold task to 
account for differences in haemodynamic responsiveness in stroke patients (van Oers et al., 
2010). One advantage of using the Bright and Murphy (2013) approach, compared to the 
method used in that study, is that it quantifies the end-tidal CO2 changes to the breath-holds. 
This compensates for variability in task performance across the patients, providing more 
reliable quantification of the CVR. The end-tidal CO2 measure provides an accurate model of 
the expected BOLD response for an individual patient, allowing for the different delays in the 
breath-hold response across varying brain regions. In addition, the use of paced breathing 
between breath-hold challenges in the Bright and Murphy (2013) method leads to a more 
consistent baseline condition, and thus a less variable measure (Scouten and 
Schwarzbauer, 2008). Finally, the Bright and Murphy (2013) approach uses end-expiration 
measures, avoiding the biphasic BOLD response that is observed in end-inspiration 
challenges (Thomason and Glover, 2008). This leads to a more repeatable starting point for 
the breath-hold challenge, resulting in improved reproducibility (Scouten and Schwarzbauer, 
2008).  
 
The purpose of the current study is to demonstrate the feasibility of this breath-hold 
technique in patients with stroke, and to determine whether, in this cohort, alterations in CVR 
in the peri-infarct tissue over time might result in misinterpretation of group-level task-related 
BOLD signal changes. Three methods of analyzing the data were investigated: GlobOpt, in 
which a single model of the BOLD response was derived from the end-tidal CO2 trace; 
VoxOpt, when the delay between the end-tidal CO2 and fMRI time series was allowed to 
vary on a voxel-wise basis to account for slower regional haemodynamic responses; and 
RHsig, a method by which a BOLD model was derived from the contralesional right 
hemisphere and does not require measurement of the end-tidal CO2. The CVR measures 
were compared in healthy, peri-infarct tissue, and infarcted tissue at two time points after the 
ictus, in the sub-acute and chronic phase. The peri-infarct tissue was specifically included in 
the analysis as some studies have attributed the level of BOLD signal change in this region 
to stroke recovery (Heiss et al., 1999; Heiss et al., 2006; Rosen et al., 2000; Saur et al., 
2006). The results demonstrate the utility of this method to assess CVR in a cohort of 
patients with stroke, and suggest that inclusion of this protocol in longitudinal BOLD studies 
of stroke recovery will allow more confident interpretation of group results.                           
Methods 
Participants 
 
Forty-six stroke patients (referred to as the PT group) with left lateralized cerebral infarction 
were scanned (30 male, average age 61.2 years, range 26-79 years). Table 1 shows their 
demographic data, including cerebrovascular risk factors, details of the size and site of the 
stroke lesion, the mode and outcome of vascular imaging, and the timing of the fMRI scans. 
The majority of patients had embolic stroke that was either from a cardio-embolic source 
(e.g. atrial fibrillation, or patent foramen ovale), or artery-to-artery embolism (e.g. from the 
carotid tree). There were 18 patients with occlusive arterial disease either in the intracranial 
vessels (e.g. due to stenosis or fresh thrombus) or dissection in the carotid tree. 
 
Twenty-four patients were scanned in the sub-acute phase post-stroke (SPPS, also referred 
to as Sess1) and 42 in the chronic phase post-stroke (CPPS, also referred to as Sess2) (Fig. 
1a). Mean time after stroke for SPPS was 14 days (range 5-28 days) and for CPPS was 114 
days (range 84-200 days). Additionally, 26 healthy volunteers (referred to as the HV group) 
were scanned (9 male, average age 56.5 years, range 37-78 years), 17 of whom were 
scanned again after approximately 100 days. There was no between-group differences in 
age (t-test P = 0.15) or sex (Fisher's exact test P = 0.5).  The National Research Ethics 
Service Committee (West London) approved the study. 
 
Scanning parameters 
 
MRI data were obtained on a Siemens Magnetom Trio 3 Tesla scanner. Whole brain, dual-
echo, BOLD GE-EPI images (TR=2s, TE1=13ms, TE2=31ms, voxel-size 3.5x3.5x3mm3, 36 
slices) were collected during a breath-hold task (see below). Only the second echo was 
analyzed in this study. Quadratic shim gradients were used to correct for magnetic field 
inhomogeneities within the brain, and residual field artefacts were compensated after 
acquiring fieldmap images.  A high-resolution 1mm3 isotropic T1-weighted whole-brain 
structural image was obtained.  
 
In addition, diagnostic Diffusion Weighted MRI (DWI) and apparent diffusion co-efficient 
(ADC) imaging obtained by the clinical stroke services at the time of each patient’s 
admission to hospital was available to assist with determination of the boundary of regional 
infarction (see below). DWI and ADC images were performed in a Siemens Verio 3 Tesla 
scanner via diffusion-weighted echoplanar imaging (EPI) sequences. Nineteen DWI axial 
slices were acquired at b = 0, 500, and 1000 s/mm2 covering the entire brain. Other imaging 
parameters were: TR/TE 4600/90 ms, field of view 267 x 267, matrix 192 x 192, slice 
thickness 5 mm, with 6.5 mm spacing. The ADC maps were acquired with identical 
parameters with b = 1000 s/mm2 . 
 
Breath-hold paradigm and end-tidal CO2 pre-processing 
 
Each participant performed a breath-hold task during the BOLD imaging to measure 
vascular reactivity (Bright and Murphy, 2013; Murphy et al., 2011). The task consisted of 14s 
of natural breathing, followed by 16s paced breathing, then a 15s end-expiration breath-hold 
down to an unforced depth. After the breath-hold, a quick exhalation of residual air was 
performed prior to a return to natural breathing, which allowed the measurement of end-tidal 
CO2 increases as a result of the breath-hold. This cycle was repeated six times over the 
course of the scan. The participants were trained outside the scanner and instructed to 
proceed to each stage by a series of visual pictorial and written cues presented at the centre 
of a screen.  
End-tidal CO2 traces were recorded throughout the experiment at a sampling frequency of 
200 Hz, via a nasal cannula attached to a Medrad Veris capnograph. The recorded end-tidal 
CO2 was converted to units of mmHg. A home-grown peak-detection algorithm was used to 
determine end-tidal CO2 values by determining the partial pressure of CO2 at the end of 
each breath. A linear interpolation was made between the end-tidal CO2 measure of the final 
breath before the breath-hold and the quick exhalation CO2 measure after the breath-hold. 
After this interpolation, a scale invariant convolution with a HRF was performed so that the 
scaling of the end-tidal CO2 regressors remains the same. Convolution with a standard 
double gamma variate HRF (Friston et al., 1998) was performed because it has been 
demonstrated that more variance can be explained in the BOLD breath-hold data (Murphy et 
al., 2011). In this way, the amplitude of the regressors reflects the true increase in end-tidal 
CO2 so that a quantitative measure of CVR could be made.   
 
fMRI pre-processing  
 
The BOLD breath-hold data were corrected for motion using AFNI’s 3dvolreg program by 
performing a rigid body alignment of each volume to the middle volume (http:// 
). Each voxel’s time series was converted to a %BOLD signal time 
series by dividing by the mean across time points. A global %BOLD time series was 
calculated for each participant by averaging over all voxels in the brain. Linear drifts were 
removed from the data. No smoothing was performed to avoid contamination of CVR values 
between different regions. 
 
Analyses of breath-hold data - GlobOpt, VoxOpt and RHsig 
 
With the aim of determining the best way to analyze the breath-hold data, three analyses 
were performed: Global Optimization (GlobOpt), Voxel-wise Optimization (VoxOpt) and Right 
Hemisphere Signal (RHsig) (see Fig. 1c). First, to remove delays between the BOLD data 
and the end-tidal CO2 trace that are caused both by physiological processes (such as the 
time for alveolar diffusion of CO2 in the lung, and the time for blood to travel between the 
lungs and brain) and by the experimental apparatus (delays along the long sampling line 
between the participant in the MR scanner and the capnograph), the delay was optimized to 
the corresponding global BOLD signal (see top panel in figure 1c). In practice, this was 
performed by temporally shifting the end-tidal CO2 trace between -15s and +15s in 0.1s 
steps, to find the delay that explained the most variance in the global BOLD signal. This 
globally-optimized CO2 trace then formed the regressor for the GlobOpt analysis; that is, it 
was fitted to each voxel’s time series with a general linear model (GLM) using AFNI’s 
3dDeconvolve function.  The beta weight from the regression for each voxel gives the 
breath-hold response in that voxel in units of %BOLD signal change per mmHg change in 
end-tidal CO2.  
 
The VoxOpt analysis differed from the GlobOpt analysis by allowing the CO2 delay to be 
optimized on a voxel-wise basis. In practice, a similar analysis was performed where the 
CO2 trace was included as a regressor in a GLM. This was repeated for each delay of the 
CO2 trace (-15s to +15s in 0.1s steps from the globally optimized delay value). On a voxel-
wise basis, the delay at which the GLM explained the most variance in that voxel was 
chosen as the optimal delay. Again, the beta weight in that voxel for that delay gave the 
breath-hold response in units of %BOLD signal change per mmHg change in end-tidal CO2.  
 
The final analysis, RHsig, provides a way of obtaining breath-hold response maps if the CO2 
trace is unavailable or of too poor a quality to use. If an area of healthy tissue can be 
defined, the average BOLD response across that region provides a good model of the 
expected breath-hold response that can be included as a regressor in a GLM. In the RHsig 
analysis, it was assumed that the average response over the entire right hemisphere is a 
good representation of the BOLD signal response to the breath-hold challenge. A similar 
approach was used by van Oers and colleagues (van Oers et al., 2010). This average was 
fitted to each voxel in a GLM, and the derived beta weight for that voxel was the breath-hold 
response in units of %BOLD (as a ratio of the %BOLD signal change of the RHsig, i.e., 
100% indicates a signal with the same amplitude as the RHsig time series).  
 
Lesion, Peri-infarct and healthy tissue masks 
 
Individual 3D lesion masks were manually delineated by a neurologist (FG) and verified by a 
second neurologist (RJSW). These were drawn one slice at a time, on T1-weighted images 
using FSLView (http://www.fmrib.ox.ac.uk/fsl/), with additional guidance from the diagnostic 
acute post-stroke DWI and ADC sequences that were available in 41 subjects. DWI 
sequences reveal the early infarct with high contrast, and were used to guide the boundaries 
of the lesion on the high resolution T1-weighted structural images (Saur et al., 2006; Mah et 
al., 2012). Similar lesion identification based on T1-weighted images is commonly used in 
functional neuroimaging studies that investigate recovery of cognitive functions after stroke, 
which can arguably be confounded by changes in CVR (Bates et al., 2003; Brownsett et al., 
2014; Dronkers et al., 2004; Crinion et al., 2006, Teki et a., 2013, Saur et al., 2006). 
Identification of the lesion manually, is considered gold standard when evaluating the 
efficacy of automated lesion segmentation algorithms (Mah et al., 2014; Seghier et al., 
2008). Session specific lesion masks were defined independently for each of the SPPS and 
CPPS scans.  
Two patients had acute infarcts that included lesions (maximum volume 1.4 cm3) in the right 
hemisphere in addition to the acute infarct in the left hemisphere (Fig. 1a). These were 
included in the acute lesion mask. Five patients had an additional remote and small chronic 
lesion (range of lesion volume: 0.09 – 30.6 cm3) that was excluded from the acute lesion 
mask. 
 
A schematic of the masks used in this study is shown in Figure 1b. The acute lesion mask 
was denoted L-Lesion since the acute stroke lesions were confined to the left hemisphere in 
the majority of cases, and predominantly left-lateralized in the few patients with bilateral 
acute strokes. A peri-infarct tissue mask, L-PeriInfarct, was defined for each patient by 
dilating the individual’s L-Lesion by 10mm and then removing voxels that were in L-Lesion. 
The remaining left hemisphere voxels outside L-Lesion and L-PeriInfarct constituted the L-
Healthy mask. Homologous masks were defined in the right hemisphere and were named R-
Lesion, R-PeriInfarct and R-Healthy. This was done by transforming the left hemisphere 
masks into Montreal Neurological Institute (MNI) standard space (see below), then flipping 
about the left/right plane, and finally transforming it back into individual subject space. R-
Lesion, R-PeriInfarct and R-Healthy contained unaffected tissue. Full left and right 
hemisphere masks comprising of all voxels (including those in the lesion and peri-infact 
regions) in the hemisphere were also defined and called L-Hemi and R-Hemi, respectively. 
These were the only masks used for the HV group. 
 
The high-resolution structural images were registered to the MNI space using FMRIB’s 
(http://www.fmrib.ox.ac.uk/fsl/) Linear Image Registration Tool (FLIRT) with 12 degrees of 
freedom and cost-function masking in order to avoid the known problem of stretching normal 
tissue to fill the infarct during standard registration (Brett et al., 2001). The final 
transformation matrix was used to transform each mask to standard space as stated above. 
 
------------------------------ 
Insert Figure 1 
------------------------------ 
 
Breath-hold response comparisons 
 
Breath-hold responses for each of the three analyses were averaged over each mask for 
comparison. However, to remove voxels in which no breath-hold response was observed 
(e.g. a white matter voxel in which blood volume is low), each mask was thresholded on the 
basis of both the individual participant and the analysis method. A liberal threshold of R2 = 
0.03 (P = 0.05, for the number of time points with no correction for multiple comparisons) 
was used. If the GLM did not explain this amount of variance in a voxel’s data, the voxel was 
removed from the mask. This ensured that averages across the masks were not skewed by 
voxels in areas of post-stroke atrophy that may show no response. In each mask, both the 
percentage of voxels surviving this threshold and their average variance were calculated for 
all participants. Comparisons between analysis methods and across masks were made 
using paired and unpaired t-tests. Specifically, differences in the values in each mask across 
the analysis methods were tested using paired t-tests. Similarly, differences within analysis 
method but across the masks were tested using paired t-tests. Unpaired t-tests were used to 
test differences between the HV and PT groups in the L-Hemi masks. These results are 
presented in Figure 2 and discussed below.  
 
The average voxel-wise delays across the masks, calculated using the VoxOpt analyses, 
were also compared for both the SPPS and CPPS time points. The average delay difference 
was calculated in the HV L-Hemi, PT L-Healthy, PT L-PeriInfarct and PT L-Lesion masks 
with the corresponding delay in the homologous mask as the baseline. In this way, no 
difference in delay between the right and left hemisphere yields a value of 0. T-tests against 
0 determined whether the delays were significantly different between the hemispheres. The 
results are shown in Figure 3 and discussed below.  
 
CVR and %BOLD change responses were compared across left and right masks and SPPS 
and CPPS time points for both the VoxOpt and RHsig analyses, respectively. Paired t-tests 
were used to determine significant differences between masks within analysis methods and 
between time points. Unpaired t-tests were used to compare the PT and HV groups. The 
results are shown in Figure 4 and discussed below.  
 
Finally, to determine whether the breath-hold responses in the PT group change over time 
from SPPS to CPPS, the Sess1 and Sess2 results from the 20 patients that provided data 
for both phases were compared. Paired t-tests were used to compare CVR results in each of 
the masks across the time points. These results are shown in Figure 5 and are discussed 
below. 
 
 
Results 
 
Lesion distributions 
 
Stroke patients with recent left lateralized infarcts were chosen to take part in the study. 
Figure 1a shows the distribution of the lesions across the participants at each of the two 
phases, SPPS and CPPS. For the 24 patients scanned at SPPS, the mean percentage of 
left hemisphere voxels deemed to be in L-Lesion was 1.6%, maximum 9%. L-PeriInfarct  
comprised a mean of 7% of left hemisphere voxels, maximum 22%. In the 42 patients 
scanned at CPPS, L-Lesion comprised a mean of 3.2% of left hemisphere voxels, maximum 
21.2%, and L-PeriInfarct  10.8%, maximum 28.8%. In the 20 patients scanned at both SPPS 
and CPPS, the mean lesion size reduced from 1.78% to 1.28% of left hemisphere voxels, a 
small but significant difference (t = 3.2, P = 5 x 10-3).  
 
Motion related to the breath-hold task 
 
The average scan motion was calculated as the mean frame-wise displacement (FWD) 
using the method described by (Power et al., 2012). Across both sessions, the mean FWD 
was 0.21 ± 0.13 in the PT group and 0.17 ± 0.08 in the HV group. An insignificant trend (P = 
0.06) towards greater motion in the PT group versus the HV group was observed.  
 
End-tidal CO2 and the global BOLD signal 
 
For the GlobOpt analysis, the delay at which the CO2 trace explained the most variance (as 
measure by R2) in the BOLD signal was chosen (see Fig. 1c top panel). The average R2 did 
not differ in either the PT group or the HV group between the first and second time points 
(PT Sess1 = 0.38 ± 0.28; PT Sess2 = 0.38 ± 0.24; HV Sess1 = 0.58 ± 0.21; HV Sess2 = 
0.47 ± 0.22). However, more global signal variance was explained by the CO2 trace in the 
HV group versus the PT group (t = 3.2, P = 2 x 10-3, combining the data across both 
sessions).  
 
Analysis methods comparison 
 
Three types of breath-hold analyses were compared: GlobOpt, VoxOpt and RHsig. Figure 2 
shows the relative performance of each of the methods by plotting the percentage of voxels 
that passed threshold in each mask (top panel), and the average variance explained in each 
mask across the participants for Sess1 (similar results were observed in Sess2). Results 
from the HV group are shown with grey bars. The percentage of voxels that passed 
threshold in left hemisphere masks, L-Hemi, in this group was 53.1 ± 8.9% for the GlobOpt 
method, increasing to 68.6 ± 7.4% for the VoxOpt analysis and 64.1 ± 5.7% for the RHsig 
method. Both the VoxOpt and RHsig values were significantly greater than the GlobOpt 
values (P < 10-7 and   P = 9 x 10-5, respectively). In the HV group, the variance explained in 
L-Hemi voxels was 13.7 ± 3.7%, 14.3 ± 3.6% and 17.9 ± 3.4% for the GlobOpt, VoxOpt and 
RHsig analysis methods, respectively. Again, both the VoxOpt and RHsig values were 
significantly greater than the GlobOpt values (P < 10-7 and P = 9 x 10-6, respectively) with the 
RHsig analysis also explaining significantly more variance than the VoxOpt method (P = 6 x 
10-5). 
 
Similar trends were observed in left hemisphere mask, L-Hemi, of the PT group, with 
significantly less voxels passing threshold and significantly less variance explained with the 
GlobOpt analysis than both the VoxOpt and the RHsig analyses methods (% voxels: P < 10-7 
and P = 2.8 x 10-5, respectively; variance explained: P = 1.4 x 10-3 and P = 1.2 x 10-5, 
respectively). However, in all three analyses methods, the results were lower in L-Hemi in 
the PT group compared the HV group. Less voxels passed threshold in L-Hemi of the PT 
group compared to the HV group (GlobOpt, P = 2 x 10-3; VoxOpt, P = 4 x 10-4; and RHSig, P 
= 9 x 10-3). A trend was observed for more variance explained in the HV compared to the PT 
group for the GlobOpt analysis (P = 0.014), with significantly more variance explained in 
both the VoxOpt and RHsig analyses (P = 8.6 x 10-3 and P = 7.2 x 10-3, respectively). A 
similar comparison between PT and HV in the R-Hemi mask, in which areas should be 
unaffected, also shows decreases. Significantly less voxels pass threshold in the PT group 
for GlobOpt and VoxOpt analyses (P = 9.4 x 10-3 and P = 2.0 x 10-3). A trend for a reduction 
in the amount of variance explained in the PT is observed in the R-Hemi masks for all 
analyses methods, with VoxOpt reaching significance (P = 3.5 x 10-2). This suggests that 
voxel time series are noisier in the PT group than the HV group. 
 
In the PT group, L-Hemi included not only tissue not directly affected by ischemic damage 
but also the lesion and the peri-infarct masks. Since this may have caused the lower values 
in the PT group compared to the HV group, L-Healthy, L-PeriInfarct  and L-Lesion were also 
compared in Fig. 2. For all three analyses, the number of voxels that passed the threshold in 
each mask, and the variance explained, reduced from L-Healthy to L-PeriInfarct  and then to 
L-Lesion. Only in the GlobOpt analysis was the reduction in the number of voxels significant 
(L-Healthy versus L-PeriInfarct , P = 4.7 x 10-4; L-Healthy versus L-Lesion, P = 1.7 x 10-4). 
For the measure of explained variance, all analyses showed significant reduction from L-
Healthy to the other two masks. For example, in the VoxOpt analysis, the variance explained 
in L-Healthy was 11.3 ± 4.1%, which reduced significantly to 9.5 ± 4.1% in L-PeriInfarct  (P = 
1.7 x 10-3) and to 8.6 ± 6.1% in L-Lesion (P = 3.3 x 10-3).  
 
------------------------------ 
Insert Figure 2 
------------------------------ 
 
Delays in breath-hold responses relative to the contralesional hemisphere 
 
The VoxOpt analysis allowed for a variable delay between the CO2 trace and each voxel’s 
time series, independent of other voxels. Fig. 3 shows delays in the left hemisphere masks 
compared to their homologous mask in the right hemisphere. No difference in delays is 
defined as 0 on this graph. In the HV group, who were also scanned at two time points, the 
relative delay in L-Hemi was -0.03 ± 0.67s and -0.15 ± 0.71s for the Sess1 and Sess2, 
respectively. Neither was significantly different from zero. Similarly, the response in L-
Healthy in the PT group was not significantly delayed relative to the homologous right 
hemisphere region, with mean delays of 0.03 ± 0.89s and -0.02 ± 0.87s for the Sess1-SPPS 
and Sess2-CPPS data, respectively. The responses in L-PeriInfarct and L-Lesion showed a 
significant delay compared to their homologous right hemisphere regions at Sess1-SPPS, 
with delays of 1.14 ± 2.4s (P = 0.03) and 1.94 ± 4.34s  (P = 0.04), respectively.  Likewise at 
Sess2-CPPS, the responses in L-PeriInfarct  and L-Lesion were also significantly delayed 
compared to their right homologues with delays of 1.24 ± 2.14s (P = 5x10-4) and 1.83 ± 
3.27s (P = 7x10-4), respectively. This finding demonstrates the need to account for regional 
variability in delays to the CO2 trace in stroke-affected areas during breath-hold analyses. 
These delays do not appear to recover over the time periods tested in this study. 
 
 
 
------------------------------ 
Insert Figure 3 
------------------------------ 
 
Breath-hold responses across all participants 
 
The average breath-hold responses across all participants are displayed in Fig. 4 for the 
VoxOpt (top panel) and RHsig (bottom panel) analyses. For the HV group, values are shown 
in L-Hemi and R-Hemi for both Sess1 and Sess2. For the PT group, both Sess1-SPPS and 
Sess2-CPPS, the results of the ipsilesional mask are displayed in grey bars (L-Healthy, L-
PeriInfarct  and L-Lesion) and results from the right hemisphere are depicted in white bars 
(R-Healthy, R-PeriInfarct  and R-Lesion). 
 
------------------------------ 
Insert Figure 4 
------------------------------ 
 
In the HV group, similar breath-hold response levels were observed in both hemispheres 
and across sessions. For the VoxOpt analysis, Sess1 showed mean responses of 0.32 ± 
0.09 and 0.31 ± 0.09, and the corresponding values for Sess2 were 0.30 ± 0.07 and 0.29 ± 
0.06, for R-Hemi and L-Hemi, respectively (units: %BOLD per mmHg change in end-tidal 
CO2). For the RHsig analysis, the average responses were 147 ± 11 and 141 ± 12 for 
Sess1 and 149 ± 12 and 142 ± 15 for Sess2 (units: %BOLD). Although the differences were 
small between hemispheres, they were significant for the RHsig analysis in both Sess1 (P = 
2.1 x 10-4) and Sess2 (P = 9.6 x 10-3). This might be expected, because the regressor for the 
RHsig analysis was drawn from R-Hemi, and therefore was a slightly better fit to the voxels 
in that hemisphere. However, a similar significant difference was also observed for the 
VoxOpt analysis in both Sess1 (P = 5.9 x 10-3) and Sess2 (P = 0.023). 
 
In the PT group, similar levels of response compared to the HV group were observed in the 
healthy tissue masks. For the VoxOpt analysis, the response in L-Healthy was 0.29 ± 0.12 
and 0.30 ± 0.10 for Sess1 and Sess2, respectively (%BOLD per mmHg). The corresponding 
results for the RHsig analysis were 143 ± 30 and 143 ± 17 (%BOLD). For the two methods, 
there was a drop in response when going from Healthy to PeriInfarct to Lesion in both the 
stroke-affected left hemisphere masks as well as the contralesional right hemisphere masks. 
For example, at SPPS with the VoxOpt method, the response dropped from 0.29 ± 0.12 to 
0.21 ± 0.09 (P = 4x10-5), and to 0.19 ± 0.17 (although not significantly, P = 0.1) in L-Healthy, 
L-PeriInfarct  and L-Lesion. Similar declines from 0.30 ± 0.12 to 0.23 ± 0.10 (P = 5.3 x 10-4) 
and then to 0.19 ± 0.11 (P = 2 x 10-3) were also observed in the right hemisphere. This 
demonstrated that the definition of the masks changed the response levels on the 
supposedly unaffected right hemisphere side.  
 
In the comparison between left and right hemisphere masks, the RHsig method appears to 
have distinguished the affected ipsilesional from the unaffected contralesional masks better, 
because the observed decline in response was greater on the left side (assuming that we 
would expect a decline in CVR on the lesioned side). For example, at CPPS the response 
difference was 156 ± 16 in R-Healthy compared to 113 ± 61 in R-Lesion, but on the affected 
side the difference was much greater, 142 ± 17 compared to 75 ± 56. Although, the left/right 
differences in the VoxOpt analysis appear small, paired t-tests showed differences in 
Healthy (Sess1, P = 1.1 x 10-3; Sess2, P = 8.3 x 10-4) and PeriInfarct  (Sess1, P = 7.8 x 10-4; 
Sess2: P = 9.5 x 10-4) but not Lesion in both sessions. The same comparisons in the three 
masks for the RHsig analysis showed more significant differences: P = 6.4 x 10-4, P = 4 x 10-
4 and P = 0.015 for Sess1-SPPS; P < 10-7, P < 10-7 and P < 3.6 x 10-3 for Sess2-CPPS, 
respectively. 
 
------------------------------ 
Insert Figure 5 
------------------------------ 
 
Longitudinal changes in breath-hold responses in 20 patients with two scans 
 
To determine whether reduced CVR recovers over time, Sess1-SPPS and Sess2-CPPS  
were compared in the 20 patients who were scanned twice (Figure 5).  For the VoxOpt 
analysis method (top panel) at the SPPS time point (grey bars), there was no significant 
difference between the mean responses in the R-Hemi and L-Healthy masks (0.29 ± 0.13 
and 0.28 ± 0.13, respectively). The breath-hold responses were significantly reduced to 0.20 
± 0.10 in the L-PeriInfarct  mask (p = 6.7 x 10-4). Although the L-PeriInfarct  had a similar 
response to the L-Lesion mask (0.19 ± 0.18), due to a large standard deviation of the L-
Lesion responses, the difference between the L-Lesion and L-Healthy was not significant (P 
= 0.093). Almost identical values were observed for all four masks at CPPS (white bars). 
Importantly there was no significant difference between SPPS and CPPS in all the masks (P 
> 0.5).  
 
Using the RHsig analysis (bottom panel of Figure 5) at the SPPS time point (grey bars), the 
breath-hold response in the L-Healthy mask was significantly less than that in R-Hemi mask 
(134 ± 29 and 153 ± 23, respectively: P = 2.8 x 10-3). Again, since the RHsig draws its 
regressor from the right hemisphere, this may not be surprising. There was a significant 
reduction from the L-Healthy response to 96±56 in the L-PeriInfarct  mask (P = 8.1 x 10-4) 
and to 75 ± 99 in the L-Lesion mask (P = 6.5 x 10-3). As with the VoxOpt analysis, no 
differences existed between responses in the SPPS and CPPS time points (P > 0.2), 
demonstrating that reductions in the breath-hold response in the Lesion and PeriInfarct  
masks did not recover over the time course of this study.  
 
Results summary 
 
The VoxOpt and RHsig analyses fit the breath-hold data better than the GlobOpt analysis 
(Fig. 2). Delays in the breath-hold response in the L-PeriInfarct and L-Lesion masks are 
observed in the PT group at both the SPPS and CPPS time points (Fig. 3). At both time 
points, the CVR measures decrease from the Healthy to the PeriInfarct to the Lesion regions 
(Fig. 4). The decreased CVR in the L-PeriInfarct and L-Lesion masks does not recover over 
time (Fig. 5). 
 
Discussion 
 
Erroneous interpretation of BOLD fMRI group results can be caused by stroke-induced 
changes in cerebrovascular reactivity (CVR). Bright and Murphy (2013) have previously 
established that CVR can be reliably quantified with breath-hold tasks, even when poorly 
performed, demonstrating that this approach is useful in patients who may not comply fully 
with the task. Since stroke has a vascular etiology, changes to CVR, especially within the 
infarct and the peri-infarct tissue, might be expected, making this a pathology for which this 
simple measure of CVR may be well utilized.  
 
In the present study, patients with left hemisphere infarcts were examined. In the sub group 
of patients that were scanned twice, SPPS and CPPS time points were approximately 4 
months apart. A steady state of recovery is assumed at the CPPS time point since it has 
been shown that clinically, maximum recovery has been reached after 3 months, beyond 
which the rate of recovery plateaus and very little further recovery occurs ((Laska et al., 
2001; Pedersen et al., 1995; Ward et al., 2003). 
 
In all patients, masks of four separate regions were defined: the lesion itself (L-Lesion); the 
peri-infarct tissue (L-PeriInfarct); the regions in the left hemisphere unaffected by stroke (L-
Healthy); and the unaffected contralesional right hemisphere (R-Hemi). The peri-infarct 
tissue was arbitrarily defined as a 10mm wide region around the lesion. This mask was 
included in the analysis as some studies have attributed activity or lack of activity, in the peri-
infarct tissue to stroke recovery (Heiss et al., 1999; Heiss et al., 2006; Rosen et al., 2000; 
Saur, 2006; Ward et al., 2003). Although this mask was arbitrarily defined and may not fully 
overlap with affected areas, it was included as an example of a region that might have 
reduced CVR. In a BOLD study investigating recovery after stroke, any other region could be 
analysed in a similar way to determine if CVR changes are likely to cause interpretability 
problems for that region.   
 
One aspect of the lesion and peri-infarct BOLD data that might change compared to healthy 
tissue is the response delay to the breath-hold. Previously, studies have used the end-tidal 
CO2 trace as a regressor in a GLM (Bright and Murphy, 2013; Murphy et al., 2011) to 
produce a CVR measure that is comparable across subjects. If a region has a delayed 
response that is unaccounted for, the CVR measure might be artificially reduced. For this 
reason, we performed two methods of analysis with the CO2 trace: GlobOpt and VoxOpt. 
The GlobOpt method represents the standard analysis for breath-hold data in which the 
same regressor is used for all voxels. The VoxOpt analysis allows for a voxel-wise delay. 
Fig. 3 demonstrates that the delay between the responses within the peri-infarct and lesion 
tissue response compared to the responses in their homologous regions on the contralateral 
side can be appreciable (1.24 ± 2.14s (P = 5x10-4) and 1.83 ± 3.27s (P = 7x10-4), 
respectively). This can explain why less voxels passed threshold in GlobOpt analysis versus 
the VoxOpt analysis (see Fig. 2). For this reason, the VoxOpt analysis was considered 
superior to the GlobOpt analysis, which was dropped from further study. 
 
The VoxOpt analysis requires an end-tidal CO2 trace, which may not be available in all 
situations. In addition, patients may have difficulties using the nasal cannula, especially if 
they prefer to breathe through the mouth, or the equipment may not be available in all 
settings. The finding that more global signal variance is explained by the end-tidal CO2 trace 
in the HV group versus the PT group suggests that the end-tidal CO2 recordings in the 
patient group may be less reliable. For this reason, the RHsig analysis, in which the model of 
breath-hold signal change is derived from the contralesional hemisphere, was also 
compared. A similar number of voxels passed threshold with this method compared to the 
VoxOpt method. However, the RHsig method also explained significantly more variance in 
those voxels that passed threshold (Fig. 2). Perhaps this is not so surprising since the 
regressor derived from the RHsig is more likely to resemble a BOLD response than an end-
tidal CO2 trace convolved with a standard HRF. The advantages of the RHsig method are 
that it is a better fit to the individual voxel BOLD responses, and it does not need end-tidal 
CO2 traces that require equipment and setup time that may not result in accurate recordings. 
On the other hand, there are a number of disadvantages to the RHsig compared to the 
VoxOpt technique: it may not be truly comparable across subjects, since it is not a 
quantitative measure and, therefore, not suitable for correcting task-related BOLD 
responses; it requires an assumption of where unaffected regions lie (indeed, in this study, 7 
of the R-Hemi masks were slightly contaminated by small lesions in the right hemisphere); it 
does not account for delays between the model and a voxel’s BOLD response; the model is 
an average over voxels that may have differing delays, and will therefore represent a more 
dispersed HRF; and finally, the CVR measures are biased towards the mask from which the 
regressor is derived, in this case R-Hemi, and so may not be reliable across the entire brain.  
 
Since it was difficult to determine which analysis approach was superior, results from both 
VoxOpt and RHsig analyses were investigated further. Comparisons of the responses in 
healthy unaffected tissue in the PT group with responses in the HV group showed no 
differences (Fig. 4). Although the number of voxels passing threshold is less, this suggests 
the CVR measures are as reliable in the patient group as the healthy controls. In both 
analyses, the CVR measures reduces as the mask size decreases (from Healthy to 
PeriInfarct and then Lesion) on both the stroke-affected left hemisphere and the 
contralesional right hemisphere. It is possible that this represents a reduction in CVR due to 
the anatomical location of the masks. However, since the lesions are in largely 
heterogeneous locations (Fig. 1), it is more likely that this reduction is simply a function of 
mask size. 
 
The interesting question is how the masks on the left side compare with their homologous 
masks on the right. A small but significant difference in CVR between the healthy tissue 
masks of the right and left hemisphere for the PT group might be indicative of increased 
cerebrovascular disease on the stroke-affected left side of the brain. However, since a 
similar small significant difference is observed between the L-Hemi and R-Hemi mask in the 
HV group, it is difficult to determine whether this is the case. For the peri-infarct mask 
compared to its homologue, small but significant differences were observed with the VoxOpt 
analysis with much larger and significant differences observed with the RHsig analysis. Only 
the RHsig analysis showed differences in CVR between the lesion and its homologue (Fig. 
4). If we expect that CVR is reduced in the lesion, this might suggest that the RHsig is better 
at distinguishing CVR changes in that area. However, from Figure 3 we know that there was 
a delay in the BOLD response in the lesion that was not accounted for by the RHsig 
analysis, which might have lead to the reduced CVR measures in the lesion compared to its 
homologue. From Figure 2, we can observe that the number of voxels that passed threshold 
was reduced in the lesion but it is possible that these voxels had intact CVR, albeit delayed, 
which the VoxOpt analysis captured but the RHsig method could not. Although differences 
exist, both methods provide similar interpretations of the data.  
 
It is important to note that a breath-hold challenge results in mild hypoxia alongside the 
intended hypercapnia. Since oxygen is vasoactive, this might directly influence the BOLD 
contrast (Bulte et al., 2012). A previous study has shown that breath-hold induced changes 
in end-tidal O2 and CO2 traces are significantly negatively correlated (Bright and Murphy, 
2013), thus their respective effects on BOLD signal changes are difficult to disentangle. 
However, it has been shown that there is minimal impact on cerebral blood flow when end-
tidal O2 ranges from 60-150 mmHg (Brugniaux et al., 2007); all changes to the breath-hold 
task fall well within this range. A recent study comparing CVR measures derived from 
breath-hold paradigms and gas challenges demonstrated that mild hypoxia caused by 
breath-holds did not significantly alter CVR results compared to an iso-oxic CO2 challenge 
(Tancredi and Hoge, 2013).These studies indicate that the mild hypoxia caused by the 
breath-hold challenge should not influence the CVR values in this study. 
 
The peri-infarct region is important when studying stroke recovery. Many longitudinal BOLD 
fMRI studies focus on activity in the peri-infact tissue, to determine if neural activity has 
returned to what would be expected in healthy brains (Saur, 2006; Ward et al., 2003). Others 
have attributed activity in the peri-infarct region, or lack of it, to stroke recovery (Heiss et al., 
1999; Heiss et al., 2006; Rosen et al., 2000). Alterations in the peri-infarct CVR over time, 
may adversely affect the interpretation of task-related BOLD signal change in fMRI studies of 
patients in the acute stages of stroke or in longitudinal studies. In the present study, for both 
the VoxOpt and RHsig analysis methods, the CVR in the peri-infarct tissue was shown to be 
reduced compared to the healthy tissue in the stroke-affected hemisphere, but did not 
change between the sub-acute and chronic phases after the ictus (Fig. 5). These findings 
suggests that in the cohort of patients studied, a relative lack of group-level task-related 
BOLD signal in the peri-infarct tissue compared to the healthy controls, may not accurately 
reflect neural deficits. However, since CVR in the peri-infarct tissue remains unchanged over 
time, a finding of increased group-level peri-infarct activity in the chronic phase in such a 
longitudinal study is less likely to be due to changes in vascular reactivity, and may be more 
reliably interpreted as a change in neural activity in the peri-infarct tissue after stroke.  
 
 Conclusions 
 
This study demonstrates that CVR can be measured successfully in a stroke patient 
population using a breath-hold task. The resulting CVR measures can be used to 
disentangle vascular and neural changes caused by stroke, increasing confidence when 
interpreting group-level BOLD signal results in terms of neural activity (oxygen 
consumption).  A lack of CVR differences in healthy tissue between patients and controls in 
this cohort suggests that task-related BOLD signal changes in these regions should be 
unaffected by the stroke and be more representative of task-related oxygen metabolism. In 
contrast, since CVR is reduced in the stroke peri-infarct tissue, a lack of BOLD signal in that 
area compared to controls may not accurately reflect neural deficits. However, the CVR in 
the peri-infarct tissue remains unchanged over time, suggesting that any group-level BOLD 
increases in this region over time in a longitudinal fMRI study are less likely to be due to an 
improvement in vascular reactivity, and may be more confidently attributed to changes 
oxygen metabolism caused by altered neural function. This study provides a framework for 
stroke researchers to account for CVR-related confounds in BOLD fMRI stroke studies. By 
including a similar breath-hold protocol in longitudinal studies of stroke recovery and 
performing similar analyses, researchers can more confidently interpret BOLD signal 
changes by disentangling vascular and neural influences using this method. 
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Figures 
 
 
Figure 1: a) Lesion Distributions. The spatial distribution of the patient’s acute infarct lesions 
is shown for both the Subacute Phase Post Stroke (SPPS also referred to as Sess1) and 
Chronic Phase Post Stroke (CPPS also referred to as Sess2) time points. The colour-code 
of each voxel indicates how many patients had a lesion that included that voxel. The Venn 
diagram shows how many patients were scanned at each time point and the overlap 
between them. b) Masks. The schematic shows the masks used in the analysis. c) Analyses. 
The delay of each participant’s end-tidal CO2 trace was initially optimised by aligning it to the 
corresponding global BOLD signal time series. Three subsequent analyses types were 
performed. GlobOpt: the optimised CO2 trace was fitted to each voxel’s time series using a 
GLM. VoxOpt: the same CO2 trace was fitted to the voxel’s time series but was allowed to 
vary temporally to optimise the fit. RHsig: the average BOLD time series signal from the right 
hemisphere was fitted to the time series of every voxel in the brain.  
  
 Figure 2: The three analyses methods (GlobOpt, VoxOpt and RHsig) were compared across 
different masks for Sess1 (similar results were found for Sess2): the L-Hemi mask for both 
the HV and PT groups and the L-Healthy (LH), L-PeriInfarct (LP) and L-Lesion (LL) masks 
for the PT group. Grey bars depict the HV results and white bars the PT results (bars show 
means, error bars show standard deviations). The top panel shows the percentage of voxels 
in each mask that passed the liberal fitting threshold (R2 = 0.0288, P = 0.05, no correction for 
multiple comparisons) averaged across subjects in each group. The bottom panel shows the 
across voxel average variance explained in each thresholded mask, averaged across the 
subjects in each group.  
  
 Figure 3: Using the VoxOpt analysis, the delay between each individual voxel time series 
and the end-tidal CO2 time series can be calculated. With the assumption that the right 
hemisphere masks are largely unaffected by the stroke, the delay in the left hemisphere 
masks compared to their right homologous regions are shown for both the SPPS and CPPS 
time points (bars show means, error bars show standard deviations).  
  
 
Figure 4: Breath-hold responses averaged across participants (bars show means, error bars 
show standard deviations). The top panel displays results from the VoxOpt analysis and the 
bottom panel shows results from the RHsig analysis. White bars show results from masks in 
the right hemisphere and grey bars show results from the left hemisphere masks. For the HV 
group, whole hemisphere masks were used. For the PT group at the two time points (Sess1-
SPPS and Sess2-CPPS), results from three masks in each hemisphere are shown: Healthy, 
PeriInfarct and Lesion.  
  
 Figure 5: Breath-hold responses averaged across patients with a scans at both SPPS and 
CPPS time points (n = 20; bars show means, error bars show standard deviations). The top 
panel displays results from the VoxOpt analysis and the bottom panel shows results from the 
RHsig analysis. The grey bars show results from the first SPPS session and the white bars 
from the second CPPS session. In both analyses, there were no significant differences 
between the SPPS and CPPS responses in each of the 4 masks; R-Hemi, L-Healthy, L-
PeriInfarct and L-Lesion.  
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